Green Thumb Industries Wednesday Morning Brief: GTBIF Closes Q2 With 5.89 Percent Gain as Profitable MSO Thesis Enters Q3 2026 Catalyst Window

TL;DR: Green Thumb Industries (GTBIF) closed June 30 at $7.91, a +5.89% single-session advance, as the cannabis sector moved into Q3 2026 carrying the weight of unresolved rescheduling timelines and sector-wide earnings anticipation. With trailing EPS of $0.51 and Q1 FY26 revenue of $300.19M, Green Thumb remains one of the few U.S. multi-state operators sustaining […]

Organigram Holdings Tuesday Brief: BAT Partnership and International Medical Sales Define Canadian LP Thesis Into Q3 2026

TL;DR: Organigram Holdings (NASDAQ: OGI; TSX: OGI) closes Q2 2026 with a differentiated Canadian LP profile anchored by its BAT-backed research program and expanding international medical revenue. As the sector awaits DEA finalization of Schedule III rescheduling, OGI’s capital-light growth strategy and cross-border positioning offer institutional investors a distinct risk-reward profile relative to U.S. MSO […]

Trulieve Cannabis Monday Brief: Florida Market Leadership and 280E Relief Position Southeast MSO for Q3 2026 Inflection

TL;DR: Trulieve Cannabis (TCNNF) enters Q3 2026 as Florida’s dominant cannabis operator, with the state’s adult-use market expansion representing the most significant near-term volume catalyst for a company whose vertically integrated footprint was built expressly for the Florida regulatory environment. The approaching resolution of the Section 280E federal tax burden under Schedule III rescheduling represents […]

📅 Yesterday's News & Older Articles →